NCT07213310View on ClinicalTrials.gov

Drug-Drug Interaction Study to Evaluate the Effect of DWC202511 or DWC202512 With DWP16001 in Healthy Adults

PHASE1Not yet recruitingINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

November 30, 2025

Primary Completion Date

January 31, 2026

Study Completion Date

March 31, 2026

Conditions
Healthy
Interventions
DRUG

DWP16001

Tablets, Oral

Trial Locations (1)

03080

Seoul National University Hospital, Seoul

Sponsors
All Listed Sponsors
lead

Daewoong Pharmaceutical Co. LTD.

INDUSTRY